Literature DB >> 20339620

[Pharmaceutical assistance in the Brazilian public health care system].

Fabiola Sulpino Vieira1.   

Abstract

This article deals with the organization of pharmaceutical assistance within the Brazilian Public Unified Health System (Sistema Unico de Saúde, SUS) by analyzing the progress made so far and the challenges that still must be faced to ensure the right to universal therapeutic and pharmaceutical coverage in Brazil. Among the improvements, the article discusses the National List of Essential Drugs and its role to guide the supply, prescription, and dispensing of drugs within SUS. The structure of federal funding and the existing pharmaceutical programs are described, as well as the responsibilities of the Federal Government, states, and municipalities concerning allocation of financial resources. Despite the progress made, the model of access to SUS drugs has not been successful in securing universal therapeutic assistance. It is essential to consider a type of funding and organization of pharmaceutical assistance that is driven by a notion of regionalization, with financing based on health care flows rather than on the population circumscribed to a given territory. It is also essential to qualify pharmaceutical management by hiring pharmacists and support personnel, professionalizing workers, and setting up facilities with appropriate information systems and equipment.

Mesh:

Year:  2010        PMID: 20339620     DOI: 10.1590/s1020-49892010000200010

Source DB:  PubMed          Journal:  Rev Panam Salud Publica        ISSN: 1020-4989


  8 in total

1.  Access to medicines: relations with the institutionalization of pharmaceutical services.

Authors:  Rafael Damasceno de Barros; Ediná Alves Costa; Djanilson Barbosa Dos Santos; Gisélia Santana Souza; Juliana Álvares; Augusto Afonso Guerra; Francisco de Assis Acurcio; Ione Aquemi Guibu; Karen Sarmento Costa; Margô Gomes de Oliveira Karnikowski; Orlando Mario Soeiro; Silvana Nair Leite
Journal:  Rev Saude Publica       Date:  2017-11-13       Impact factor: 2.106

2.  Pharmaceutical services in primary health care: interfederative agreement in the development of pharmaceutical policies in the Brazilian Unified Health System (SUS).

Authors:  Karen Sarmento Costa; Noêmia Urruth Leão Tavares; José Miguel do Nascimento; Sotero Serrate Mengue; Juliana Álvares; Augusto Afonso Guerra; Francisco de Assis Acurcio; Orlando Mario Soeiro
Journal:  Rev Saude Publica       Date:  2017-11-13       Impact factor: 2.106

3.  Management of pharmaceutical services in the Brazilian primary health care.

Authors:  Letícia Farias Gerlack; Margô Gomes de Oliveira Karnikowski; Camila Alves Areda; Dayani Galato; Aline Gomes de Oliveira; Juliana Álvares; Silvana Nair Leite; Ediná Alves Costa; Ione Aquemi Guibu; Orlando Mario Soeiro; Karen Sarmento Costa; Augusto Afonso Guerra; Francisco de Assis Acurcio
Journal:  Rev Saude Publica       Date:  2017-11-13       Impact factor: 2.106

Review 4.  Applying a health system perspective to the evolving Farmácia Popular medicines access programme in Brazil.

Authors:  Vera L Luiza; Luisa A Chaves; Monica R Campos; Andrea D Bertoldi; Rondineli M Silva; Maryam Bigdeli; Dennis Ross-Degnan; Isabel C M Emmerick
Journal:  BMJ Glob Health       Date:  2018-02-07

5.  Medications used in pediatric cystic fibrosis population.

Authors:  Stella Pegoraro Alves; Márcia de Azevedo Frank; Denise Bueno
Journal:  Einstein (Sao Paulo)       Date:  2018-11-08

6.  Analysis of a Blended, In-Service, Continuing Education Course in a Public Health System: Lessons for Education Providers and Healthcare Managers.

Authors:  Fernanda Manzini; Eliana Elisabeth Diehl; Mareni Rocha Farias; Rosana Isabel Dos Santos; Luciano Soares; Norberto Rech; Andrigo Antonio Lorenzoni; Silvana Nair Leite
Journal:  Front Public Health       Date:  2020-11-26

7.  Can Brazil play a more important role in global tuberculosis drug production? An assessment of current capacity and challenges.

Authors:  Andre Gemal; Joel Keravec; Alexandre Menezes; Anete Trajman
Journal:  BMC Public Health       Date:  2013-03-27       Impact factor: 3.295

8.  Medication adherence and persistence of psoriatic arthritis patients treated with biological therapy in a specialty pharmacy in Brazil: a prospective observational study.

Authors:  Ana F Souza; Michael R Da Silva; Jéssica B Dos Santos; Alessandra M Almeida; Francisco A Acurcio; Juliana Alvares-Teodoro
Journal:  Pharm Pract (Granada)       Date:  2021-05-28
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.